Étude d'association entre l'asthme et le gène plasminogen activator, urokinase dans la population du Saguenay-Lac-Saint-Jean

Étude d'association entre l'asthme et le gène plasminogen activator, urokinase dans la population du Saguenay-Lac-Saint-Jean

Show other versions (1)

Mémoire numérisé par la Division de la gestion de documents et des archives de l'Université de Montréal

Bibliographic Details
Main Author:	Bégin, Philippe
Language:	fr
Published:	2012
Subjects:	Asthme Hyperréactivité bronchique Atopie Étude d'association Test de déséquilibre de transmission (TDT) Haplotypes Urokinase PLAU 10q24 Activation du plasminogène
Online Access:	http://hdl.handle.net/1866/7587

Similar Items

Étude d'association entre l'asthme et le gène plasminogen activator, urokinase dans la population du Saguenay-Lac-Saint-Jean
by: Bégin, Philippe
Published: (2012)

Marqueurs précoces non invasifs de l'inflammation des voies aériennes dans les métiers à risque d'asthme professionnel : etude dans une population d'apprentis boulangers, pâtissiers et coiffeurs
by: Tossa, Mohamed Paul
Published: (2009)

Les IgG et les IgE spécifiques aux isocyanates chez les apprentis en carrosserie automobile à risque de développer de l'asthme professionnel
by: Dragos, Mircea Claudiu
Published: (2016)

Relation entre les effets de la Bradykinine au niveau des bronchioles humaines et la synthèse endogène des époxy-éicosanoïdes
by: Tabet, Yacine
Published: (2013)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin′s Lymphoma
by: Shirin Kouhpayeh, et al.
Published: (2017-01-01)

The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-ε4 non-carriers in the Italian Alzheimer’s disease population and does not affect the plasma Aβ(1–42) level
by: Marzia Pesaresi, et al.
Published: (2007-03-01)

The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review
by: Torry A. Tucker, et al.
Published: (2021-02-01)

Specific inhibitors of urokinase plasminogen activator for treatment of cancers; In silico approach
by: Benjamin Talbot, et al.
Published: (2020-05-01)

Etude physiopathologique de l'inflammation et du remodelage bronchique dans l'asthme
by: Ozier, Annaïg
Published: (2011)

Etudes d'association prenant en compte des mécanismes complexes : application à l'asthme
by: Sarnowski, Chloé
Published: (2015)

L'expectoration induite dans le diagnostic d'asthme professionnel
by: Girard, Frédéric
Published: (2016)

Urokinase-type plasminogen activator is a modulator of synaptic plasticity in the central nervous system: implications for neurorepair in the ischemic brain
by: Manuel Yepes
Published: (2020-01-01)

Serum levels of urokinase-type plasminogen activator in healthy dogs and oncologic canine patients
by: Sofia C. Ramos, et al.
Published: (2017-08-01)

Reduced Expression of Urokinase Plasminogen Activator in Brown Adipose Tissue of Obese Mouse Models
by: Chung-Ze Wu, et al.
Published: (2021-03-01)

Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors
by: Lampelj Maja, et al.
Published: (2015-12-01)

Urokinase plasminogen activator expression in canine malignant mammary tumours by immunohistochemical study
by: Golshahi Hannaneh, et al.
Published: (2013-12-01)

Concentrations of plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in induced sputum of asthma patients after allergen challenge
by: Krzysztof Kowal,, et al.
Published: (2010-04-01)

Approche translationnelle du remodelage bronchique dans la broncho-pneumopathie chronique obstructive et l’asthme
by: Thumerel, Matthieu
Published: (2015)

Inhibitory effects of wogonin on invasion by human oral cancer cells by decreasing the activity of matrix metalloproteinases and urokinase-plasminogen activator
by: Yung-Chuan Ho, et al.
Published: (2014-06-01)

Phénotypage de l’asthme chez l’athlète
by: Côté, Andréanne
Published: (2020)

Biomarqueurs systémiques associés à l'asthme persistant ou sévère de l'enfant
by: Amat, Flore
Published: (2017)

Monitoring of chemotherapy successfulness of Platina/Taxol chemotherapy protocol by using determination of serum urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) in patients with ovarian carcinoma FIGO II
by: Dženita Ljuca, et al.
Published: (2007-05-01)

Soluble urokinase plasminogen activator receptor and its complicated role in hemodialysis (HD) patients with Covid-19 infection
by: Ioannis Griveas, et al.
Published: (2021-07-01)

Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillation
by: Noboru Ichihara, et al.
Published: (2017-10-01)

Experimental and Clinical Evidence Supports the Use of Urokinase Plasminogen Activation System Components as Clinically Relevant Biomarkers in Gastroesophageal Adenocarcinoma
by: Gary Tincknell, et al.
Published: (2021-08-01)

Implication du PAR-2 dans le remodelage musculaire lisse bronchique de la physiopathologie de l'asthme
by: Allard, Benoit
Published: (2013)

La recherche de déterminants génétiques dans l'asthme : contribution de deux méthodes génomiques
by: Madore, Anne-Marie
Published: (2009)

Urokinase-type Plasminogen Activator and Plasminogen Activator Inhibitor Induction by Etoposide in a Glioblastoma Cell Strain
by: Branko Brdar, et al.
Published: (2002-01-01)

Fibrinolysis regulation by platelets retaining plasminogen and tissue-type plasminogen activator on their surface
by: T. Grinenko, et al.
Published: (2019-12-01)

Urokinase vs Tissue-Type Plasminogen Activator for Thrombolytic Evacuation of Spontaneous Intracerebral Hemorrhage in Basal Ganglia
by: Yuqian Li, et al.
Published: (2017-08-01)

Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
by: Niaz Mahmood, et al.
Published: (2018-02-01)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies
by: Burcin Özdirik, et al.
Published: (2020-05-01)

Soluble urokinase-type plasminogen activator receptor as a biomarker of treatment response in childhood tuberculosis
by: Ery Olivianto, et al.
Published: (2019-01-01)

Inhibition of Urokinase-Type Plasminogen Activator Expression by Macelignan in Porphyromonas gingivalis Supernatant-Induced Human Oral Epithelial Cells
by: YANTI
Published: (2010-03-01)

Inhibition of Urokinase-Type Plasminogen Activator Expression by Macelignan in Porphyromonas gingivalis Supernatant-Induced Human Oral Epithelial Cells
by: YANTI
Published: (2010-03-01)

Effect of remission induction therapy on the level of soluble urokinase plasminogen activator receptor in acute myeloid leukemia
by: Eman Qassim Ahmed, et al.
Published: (2020-01-01)

Value of soluble Urokinase plasminogen activator receptor over age as a biomarker of impaired myocardial relaxation
by: Angela S. Koh, et al.
Published: (2017-11-01)

Évaluation du conflit décisionnel associé aux décisions concernant la maîtrise de l'asthme
by: Descormiers, Annick
Published: (2013)

The effect of anti-human plasminogen monoclonal antibodies on Glu-plasminogen activation by plasminogen activators
by: M. Akrami, et al.
Published: (2006-07-01)

Étude des profils de méthylation et d'expression des lymphocytes T CD4+ dans l'asthme
by: Boucher-Lafleur, Anne-Marie, et al.
Published: (2019)